Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Plano de Exercício Sanofi e APCL ultrapassa 200 participações

Číst více

BR1DGE: Eleve o seu conhecimento em DT1 para o próximo nível

Číst více

Highlights ATTD 2025

Číst více

Vidéo sur ASMD en 4 min

Niemann-Pick: Comprendre le déficit en sphingomyélinase acide en 4 minutes

Číst více

BRIGHT publication

Číst více

BRIGHT publication

The Bright study demonstrated similar efficacy and safety of Toujeo^® (Glargine 300 U/ml) compared to degludec 100 U/ml in type 2 diabetes patients who had not previously received basal insulin¹.

Číst více

BRIGHT publication

The Bright study demonstrated similar efficacy and safety of Toujeo^® (Glargine 300) compared to degludec (insulin degludec) in type 2 diabetes patients who had not previously received basal insulin¹.

Číst více

ATS 2025 Scientific Highlights

May 17–21, 2025; San Francisco, California, US

Číst více

ATS 2025 Scientific Highlights

May 17–21, 2025; San Francisco, California, US

Číst více

What's New in Pediatric Atopic Dermatitis?

Číst více

What's New in Pediatric Atopic Dermatitis?

Číst více

Real World Evidence Grafik Beyfortus^®

Číst více

Transplantační medicína

Nejnovější trendy

Plano de Exercício Sanofi e APCL ultrapassa 200 participações

BR1DGE: Eleve o seu conhecimento em DT1 para o próximo nível

Highlights ATTD 2025

Vidéo sur ASMD en 4 min

BRIGHT publication

BRIGHT publication

BRIGHT publication

ATS 2025 Scientific Highlights

ATS 2025 Scientific Highlights

What's New in Pediatric Atopic Dermatitis?

What's New in Pediatric Atopic Dermatitis?

Real World Evidence Grafik Beyfortus®

Real World Evidence Grafik Beyfortus^®